Google AI to Accelerate Drug Discovery

Alphabet's Isomorphic Labs Using AI To Discover New Pharma Drugs




                           Source:  Google & Stock AI Images

AI Could Accelerate Development & Cut Costs of New Drugs

Google's innovation incubator Alphabet is putting artificial intelligence (AI) to work for the discovery of new pharmaceutical drugs.  Alphabet has launched a new company Isomorphic Labs in the UK to deploy advancements made by Alphabet's DeepMind AI to predict the shape of proteins with "incredible accuracy".  DeepMind's AI uses a model called AlphaFold2 to predict breakthrough proteins and their shape in the human body.  This capability is said by experts to be critical in the development of breakthrough drug therapies.  

What Is the Significance of Alphabet's Move?

It has great significance on a number of levels.  This fascinating development moves Google and Big Tech deeper into the healthcare industry.  The big hope and expectation are that AI will cut the time and expense of creating a new pharma drug.  Currently it takes an average of ten years and $2.6 billion to develop a new, significant drug.  DeepMind CEO Demis Hassabis says the use of AI could mean the entire drug discovery process will be reimagined and ultimately enable the modeling and understanding "of the fundamental mechanisms of life".  Hassabis is the founder of Isomorphic Labs.  He will remain CEO of DeepMind and Isomorphic Labs although the two entities will remain separate.

AI Advancing HealthCare Treatment

The launch of Isomorphic Labs deepens Alphabet's portfolio of healthcare entities which include Verily and Calico.  Big Pharma are also deploying AI including UBC, the Belgium based biopharma company which has partnered with Microsoft to use AI and cloud computing to discover new pharma drugs.

Comments

Popular posts from this blog

Extreme Electric Surfboard

New Electric Surfboard from Sweden

Electric, New MG Cyberster Sports Car